Activity and cellular distribution of ORF3a mutants of SARS-CoV-2 variants of concern
Journal of General Virology · 2025
DOI: 10.1099/jgv.0.002135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, 2025. Verfasst von Ulrike Breitinger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, German University in Cairo, New Cairo, Egypt. Hauptthemen laut MEDLINE: SARS-CoV-2, Viroporin Proteins, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Academic Exchange Service.
Abstract (Originalsprache)
Infection with SARS-CoV-2 continues to be a threat to human health. Despite successful immunization campaigns, effective treatment of COVID-19 remains an essential need to help patients and prevent the spread of new virus strains. Viroporins are intracellular ion channels that are essential for virus replication and release, thus presenting promising pharmaceutical targets. Mutations found in variants of concern (VOC) are expected to increase the virulence of the new virus strains. Recognizing the effects of these mutations at the molecular level is essential for the development of improved therapies. Here, we characterized the putative viroporin ORF3a found in VOCs of SARS-CoV-2, using expression constructs containing a myc-tag for identification, and an optional membrane-directing signal peptide. Additionally, constructs containing N-terminal fluorescence protein tags were prepared. Expression and cell surface transport in HEK-293 cells were studied using Western blot and dot blot assays, and the cellular distribution of fluorescent-marked ORF3a was studied using subcellular organelle markers and high-resolution fluorescence microscopy. Viroporin activity of all ORF3a constructs was assessed using cell viability and metabolic assays, as well as patch-clamp recordings of recombinant ORF3a. All ORF3a mutants were expressed well in the recombinant system, and the presence of a signal peptide increased expression on the cellular surface. Intracellular distribution was similar for all variants. The VOC mutants ORF3a-S171L and ORF3a-Q57H showed reduced cytotoxic activity and sensitivity to the viroporin inhibitor rimantadine, respectively, suggesting these positions to be relevant for ORF3a function and a starting point for the search of novel antiviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, German University in Cairo, New Cairo, Egypt.
- Institute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University Würzburg, Würzburg, Germany.
- Present address: German University in Cairo, New Cairo, Main Entrance of Al Tagamoa Al Khames, New Cairo 11835, Egypt.
Förderung
- German Academic Exchange Service
Zitieren
APA
Breitinger, U., Zakaria, Z. I. S., Mahgoub, H. A., Wiessler, A. L., Tuerker, E., Villmann, C., & Breitinger, H. G. (2025). Activity and cellular distribution of ORF3a mutants of SARS-CoV-2 variants of concern. Journal of General Virology. https://doi.org/10.1099/jgv.0.002135
Vancouver
Breitinger U, Zakaria ZIS, Mahgoub HA, Wiessler AL, Tuerker E, Villmann C, et al. Activity and cellular distribution of ORF3a mutants of SARS-CoV-2 variants of concern. Journal of General Virology. 2025. doi:10.1099/jgv.0.002135
BibTeX
@article{Breitinger2025,
author = {Breitinger, Ulrike and Zakaria, Zeina Ihab Seifeldin and Mahgoub, Haya Alaa and Wiessler, Anna-Lena and Tuerker, Esra and Villmann, Carmen and Breitinger, Hans-Georg},
title = {Activity and cellular distribution of ORF3a mutants of SARS-CoV-2 variants of concern},
journal = {Journal of General Virology},
year = {2025},
doi = {10.1099/jgv.0.002135}
}
EUVIMED